Form
|
|
(Filer)
|
Received
(
Period
)
|
144/A |
 |
EYEPOINT PHARMACEUTICALS, INC. (OCUMENSION THERAPEUTICS) |
05/26/23 |
144/A |
 |
EYEPOINT PHARMACEUTICALS, INC. (OCUMENSION THERAPEUTICS) |
05/26/23 |
144 |
 |
EYEPOINT PHARMACEUTICALS, INC. (OCUMENSION THERAPEUTICS) |
05/26/23 |
8-K/A |
 |
EYEPOINT PHARMACEUTICALS, INC. |
05/23/23 (05/17/23) |
8-K |
 |
EYEPOINT PHARMACEUTICALS, INC. |
05/18/23 (05/17/23) |
4 |
 |
EYEPOINT PHARMACEUTICALS, INC. (LURKER NANCY) |
05/15/23 (05/11/23) |
10-Q |
 |
EYEPOINT PHARMACEUTICALS, INC. |
05/04/23 (03/31/23) |
8-K |
 |
EYEPOINT PHARMACEUTICALS, INC. |
05/03/23 (05/03/23) |
SC 13G/A |
 |
EYEPOINT PHARMACEUTICALS, INC. (CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP) |
05/01/23 |
DEFA14A |
 |
EYEPOINT PHARMACEUTICALS, INC. |
04/28/23 |
DEF 14A |
 |
EYEPOINT PHARMACEUTICALS, INC. |
04/28/23 (06/20/23) |
8-K |
 |
EYEPOINT PHARMACEUTICALS, INC. |
03/27/23 (03/27/23) |
8-K |
 |
EYEPOINT PHARMACEUTICALS, INC. |
03/10/23 (03/10/23) |
10-K |
 |
EYEPOINT PHARMACEUTICALS, INC. |
03/10/23 (12/31/22) |
8-K |
 |
EYEPOINT PHARMACEUTICALS, INC. |
03/02/23 (03/02/23) |
SC 13G/A |
 |
EYEPOINT PHARMACEUTICALS, INC. (RA CAPITAL MANAGEMENT, L.P.) |
02/14/23 |
4 |
 |
EYEPOINT PHARMACEUTICALS, INC. (PAGGIARINO DARIO A.) |
02/13/23 (02/09/23) |
4 |
 |
EYEPOINT PHARMACEUTICALS, INC. (GUYER DAVID R) |
02/13/23 (02/09/23) |
4 |
 |
EYEPOINT PHARMACEUTICALS, INC. (DICICCO WENDY F) |
02/13/23 (02/09/23) |
4 |
 |
EYEPOINT PHARMACEUTICALS, INC. (LANDIS JOHN B.) |
02/13/23 (02/09/23) |